July 15, 2010

Alleged Jaw Death for Patients Using Fosamax

Fosamax side effects lawyers have noted a number of cases which claim that the drug Fosamax can cause a serious condition known as osteonecrosis of the jaw (ONJ). This side effect is accused of causing extreme pain and in some cases the death of the jawbone.

The number of Fosamax claims has encouraged U.S. District Judge, John Keenan, to set up three bellwether trials. These trials are intended to aid others in out of court matters regarding Fosamax claims. In one of the bellwether trials the jury awarded $8 million dollar judgment in favor of the plaintiff. You can read about the first two Fosamax side effect trials by visiting the Product Defect News blog.

Continue reading "Alleged Jaw Death for Patients Using Fosamax" »

July 14, 2010

Lawsuits Allege Merck of Manufacturing a Dangerous Drug That Sells Under the Brand Name Fosamax

Fosamax side effects lawyers have been following claims involving the drug's alleged side effects. For a number of years an osteoporosis drug, Fosamax, has been used by patients to treat their condition. It came as a surprise to some patients when they began suffering from the drug's alleged side effect, jaw necrosis. The side effect occurs after minor dental trauma and can lead to the jawbone deteriorating then dying.

The alleged Fosamax side effect has been referred to under a number of different names, which include jaw necrosis, osteonecrosis of the jaw, ONJ, dead jaw or bis-phossy jaw. Stopping the drug does not reverse the damage to your jaw. Once you have suffered from decay of the jawbone it could be permanent.

Continue reading "Lawsuits Allege Merck of Manufacturing a Dangerous Drug That Sells Under the Brand Name Fosamax" »

July 8, 2010

West Virginia Woman Files Malpractice Lawsuit over Fosamax Dental Injury

Bonne Ford, a West Virginia woman, hired Fosamax Side Effects Lawyers to file a malpractice lawsuit against her dentist and dental clinic, Dr. Mark W. Simpson and Simpson and Simpson Dental Associates. According to AboutLawsuits.com, Ford alleges that she suffered from a jaw-related injury due to the failure of her dentist and dental clinic to ask whether she had taken the osteoporosis drug Fosamax.

Ford was scheduled for a series of surgeries to receive dental implants. Ford alleges in her lawsuit that she suffered substantial dental pain during her procedure and ultimately infection due to the negligence of the dentist.

Continue reading "West Virginia Woman Files Malpractice Lawsuit over Fosamax Dental Injury" »

July 7, 2010

Osteoporosis Drug Fosamax May Be Linked To a Number of Side Effects

Fosamax Side Effects Lawyers has observed a number of claims against the drug manufacturer Merck and Co. Recently an increased number of claims have caught the attention of the U.S. District Judge, John Keenan, who will be supervising federal Fosamax cases. Keenan has set up three bellwether trials that will aid others in out-of-court arrangements.

The Fosamax side effect claims allege the drug of serious side effects which can lead to supposed jaw death (Osteonecrosis of the Jaw). Patients who used the drug to treat osteoporosis often experience alleged symptoms after minor dental trauma.

Continue reading "Osteoporosis Drug Fosamax May Be Linked To a Number of Side Effects" »

July 6, 2010

Fosamax Side Effect Claims Continue

Reports of serious side effects have been noted by a number of Fosamax side effects lawyers. The development of an alleged side effect referred to as osteonecrosis of the jaw (ONG) has made Merck & Co. the target of a number of personal injury lawsuits. The lawsuits claim that the use of the drug Fosamax may cause a serious side effect -- osteonecrosis of the jaw -- which can potentially cause the jaw bone to deteriorate and die.

If you or a loved one are experiencing osteonecrosis of the jaw, or any other Fosamax side effect, it important to consult with your doctor for medical advice.

Continue reading "Fosamax Side Effect Claims Continue " »

July 2, 2010

Federal Bellwether Trial Overview for Fosamax

Fosamax Drug - osteonecrosis of the jaw (ONJ)


Fosamax Side Effects Lawyers have observed a number of Fosamax patients bring claims against the drug maker for an alleged side effect which can lead to supposed jaw death. The alleged side effect is called osteonecrosis of the jaw (ONJ) which prevents the bone tissue of the jaw from healing after minor dental trauma.

The osteoporosis drug maker of Fasamax has received approximately 978 cases that have been filed or are pending, according to a report in TheStreet. The U.S. District Judge, John Keenan, will be supervising federal Fosamax cases. He has set up three bellwether trials which will aid others in out-of-court arrangements. The results of the first two cases are as follows:

Continue reading "Federal Bellwether Trial Overview for Fosamax" »

July 1, 2010

Fosamax Side Effect Lawsuit Results in an $8 Million Dollar Judgment

Fosamax Side Effects Lawyers continue to observe a number of Fosamax drug cases. The drug maker of Fosamax has had more than 900 cases pending or filed which may be due to the alleged side effect osteonecrosis of the jaw (ONJ).

The New York case claims that Shirley Boles, 71, from Walton Beach, Florida, suffered jaw problems due to her use of Fosamax. Boles had been using the drug from 1997 to 2006.

Continue reading "Fosamax Side Effect Lawsuit Results in an $8 Million Dollar Judgment" »

June 30, 2010

Drug Maker Fosamax Accused of Manufacturing Defective Drug

A number of Fosamax Side Effects Lawyers have observed an increase in Fosamax drug claims. More than 900 cases have been filed or are pending against osteoporosis drug manufacturer, according to a news report in TheStreet. The claims that have been piling up against the osteoporosis drug are partly due to an alleged side effect called osteonecrosis of the jaw (ONJ). This terrifying side effect can lead to supposed jaw death.

The U.S. District Judge, John Keenan, will be supervising federal Fosamax cases. He has decided to set up three bellwether trials which will aid others in out-of-court arrangements. You can read part one of the first trial by visiting "Drug Maker Fosamax Accused of Manufacturing Defective Drug."

Continue reading "Drug Maker Fosamax Accused of Manufacturing Defective Drug " »

June 29, 2010

Drug Maker Fosamax Accused of Manufacturing Defective Drug

Fosamax Side Effects Lawyers have observed an increase in the number of claims against the drug maker Fosamax. The first of these lawsuits accuses the osteoporosis drug of causing a side effect called osteonecrosis of the jaw (ONJ). There are almost 900 patients who have made claims against the drug maker Fosamax for ONJ. The Fosamax side effect ONJ leads to supposed jaw death to patients who have used the drug over a period of time.

Continue reading "Drug Maker Fosamax Accused of Manufacturing Defective Drug " »

June 28, 2010

Fosamax Side Effects May Cause ONJ

Fosamax Side Effects Lawyers have been following a current study which has linked femur fractures to the use of the drug Fosamax. The Fosamax side effect causes a serious bone condition called osteonecrosis of the jaw (ONJ). This condition prevents the bone tissue of the jaw from healing after minor dental trauma -- such as a tooth extraction.

According to Your LegalGuide.com, one lawsuit involved a 60-year old woman who was treating her osteoporosis with the drug. Her six plus years of using the drug caused her to develop ONJ. The results were horrifying. ONJ caused rotting in her mouth which exposed bone in her jaw. Ultimately, the effects of osteonecrosis can cause a person's jaw to rot and die.

Continue reading "Fosamax Side Effects May Cause ONJ" »

February 19, 2010

Study Confirms Link between Hydroxycut and Liver Problems

The pharmaceutical liability lawyers at BISNAR | CHASE have been extremely concerned about the adverse side effects caused by dietary supplement Hydroxycut. Government health officials in May sent out strong warnings to dieters and body builders to immediately stop using Hydroxycut, a widely sold dietary supplement linked to at least one death and several cases of liver damage. Now, the American Journal of Gastroenterology is confirming fears about the serious side effects of Hydroxycut. A recent study published in the journal confirms links between this herbal weight loss supplement and liver problems.

Continue reading "Study Confirms Link between Hydroxycut and Liver Problems" »

September 3, 2009

Pharmaceutical Litigation Lawyer Concerned about Illegal Marketing Practices

The pharmaceutical litigation attorneysat BISNAR | CHASE, for the last 30 years, have fought for the rights of injured victims who suffered the devastating consequences of dangerous or defective drugs. Dangerous drug effects are also often the result of misleading marketing by drug companies. We saw an example of such corporate greed when the U.S. Justice Department announced that Pfizer, the world's largest drug maker, has agreed to pay a $2.3 billion civil penalty for trying to sell drugs for uses not approved by federal regulators. Pfizer paid the fines to settle criminal and civil allegations that it illegally sold four drugs for uses not approved by the U.S. Food and Drug Administration (FDA). When a drug is marketed or promoted for non-authorized or "off-label" uses that are not approved by the FDA, there is no question that public health and safety is at risk.

Continue reading "Pharmaceutical Litigation Lawyer Concerned about Illegal Marketing Practices" »

July 9, 2009

Victims File Zicam Class Action Lawsuits

Users of Zicam cold remedies who have lost their sense of smell as a result of using the defective drug have found themselves a Zicam lawyer in order to file for a class action lawsuit against drug manufacturer Matrixx Enterprises. According to a news article in Consumeraffairs.com, the class action lawsuits were filed in federal court in California and state court in Missouri. The California lawsuit was brought on behalf of anyone who bought Zicam while in California or from a manufacturer or other source in California within the four years preceding June 23, 2009. The Missouri lawsuit defines a class of all St. Louis County residents who bought Zicam products in the year preceding a safety warning issued by the U.S. Food and Drug Administration in June.

On June 15, 2009, the FDA warned consumers to stop using Zicam intranasal cold gels and nasal sprays after receiving more than 130 complaints from consumers whose sense of smell was completely gone or diminished from having taken these defective drugs. Apparently, zinc gluconate, one of the active ingredients in Zicam cold medications can cause irreparable and irreversible personal injury from damage to intranasal tissue.

Continue reading "Victims File Zicam Class Action Lawsuits" »

June 25, 2009

Zicam Defective Pharmaceutical Products Recalled

Matrixx Initiatives has officially announced that it will recall its Zicam intranasal cold remedies after hundreds of patients reported losing their sense of smell using the medications, the Associated Press reports. The U.S. Food and Drug Administration earlier this month issued a consumer alert about Zicam. Matrixx officials are saying that the product recall is voluntary while stating that they disagree with the FDA's safety warning, which maintains that the zinc-containing Zicam intranasal cold remedies are unsafe to use. The FDA is also alleging that the products were unlawfully marketed, an allegation which is also being challenged by Matrixx.

Continue reading "Zicam Defective Pharmaceutical Products Recalled" »

May 19, 2009

Raptiva Recall Lawyers: Drug Linked To Brain Damage in Psoriasis Patients

Raptiva recall lawyers continue to see the defective drugs effect. Gloria, a nurse from Memphis, Tennessee, talks about her Raptiva side effects in an article in Lawyers and Settlements. Gloria has been a registered nurse for 30 years. When she was prescribed the drug Raptiva for severe psoriasis, Gloria says it "worked like a charm." She stayed on Raptiva for four years and then the troubling side effects began. The muscle aches, back pains and nervous disorders were unlike any before and Gloria immediately associated them with Raptiva. She even had to use a walker for a while because of the neurological problems.

And then, last month, she got a call from her doctor saying that she needed to get off Raptiva -- that there was this severe neurological defect -- a brain damage disease called progressive multifocal leukoencephalopathy (PML) -- associated with Raptiva. Once you get PML, you go nowhere but down, Gloria's doctor told her.

This made Gloria mad, understandably so. It further aggravated her when she heard from a pharmacist that the drug company, Genentech, knew about these defective drug side effects from clinical trial overseas. They knew about the negative findings, but never shared that information here in the United States. Patients also say that there are no prominent warnings of any side effects in the literature provided with the prescription drug.

Continue reading "Raptiva Recall Lawyers: Drug Linked To Brain Damage in Psoriasis Patients" »

May 12, 2009

Hydroxycut Recall: Hydroxycut Class Action Lawsuits Brewing

We have been reporting about the Hydroxycut recall of more than a dozen Hydroxycut weight loss supplements, which are apparently causing serious liver damage among users. Among the Hydroxycut products recalled are weight loss supplements, fat burners, energy enhancers, low-carb diet aids and water loss aids. Many experts and consumer safety advocates say that the problem with Hydroxycut and other diet aids is that unlike pharmaceuticals, the U.S. Food and Drug Administration does not regulate supplements. There are no guidelines, procedures, policies or test results that a company has to go through to put these weight loss products on the market.

It's going to take a class-action lawsuit to stop the sale of these dangerous, unregulated supplements. There are already many of these class-action lawsuits brewing across the country. Bisnar | Chase has also received calls and inquiries from victims and their families on how to go about pursuing their legal options. It is important that consumers protect their rights. If you have suffered liver damage or other serious side effects as a result of taking Hydroxycut, please contact reputed product liability law firms that can help hold these defective product manufacturers accountable.

I've always found it appalling that dietary supplements are not tested for dangerous ingredients that might endanger lives. Prescription drugs must go through rigorous testing to get FDA approval before they can be sold, as they should. However, these supplements are not tested or approved by the FDA. So in the case of Hydroxycut, we actually had to wait until 23 personal injuries and one death were reported. Now lawyers who take on these cases will go out and do the research to prove that the problem was the product to start with.

Continue reading "Hydroxycut Recall: Hydroxycut Class Action Lawsuits Brewing" »

May 11, 2009

Hydroxycut Recall Lawyers: Many May Have Suffered Harmful Hydroxycut Effects

Hydroxycut recall lawyers have noted government health officials who are sending out strong warnings to dieters and body builders to immediately stop using Hydroxycut, a widely sold dietary supplement that has been linked to serious liver damage and at least one death, according to an Associated Press news report. The company that manufactures Hydroxycut has recalled 14 of its products after 23 reports of liver damage and one death of a 19-year-old boy, who died in 2007 after taking Hydroxycut. Apparently, the patients who suffered liver damage were otherwise perfectly healthy until they started using Hydroxycut.

However, Iovate Health Sciences, the manufacturer of Hydroxycut has stated that the death of the teenager in 2007 was not caused by Hydroxycut. In fact, the company claims that the "adverse events" reported are minuscule compared to the large number of people who have used and benefited from the drug Hydroxycut. Last year alone, 9 million packages of the dietary supplements were sold. Hydroxycut is advertised and marketed as a dietary supplement made with natural ingredients. Iovate officials say that their assessment of the drug's side effects is very different from that of the U.S. Food and Drug Administration. Unfortunately, no one really knows how many have been affected by this defective drug.

There is no question that dietary supplements fall through the crack when it comes to regulation. Dietary supplement manufacturers do not have to undergo a rigorous FDA screening process as other medications. However, in recent years, companies have been put under stricter requirements to alert the FDA when they learn of problems. In 2004, the government banned ephedra, an ingredient in many dietary supplements, which was linked to heart attacks, seizures and strokes. The problem is that the FDA relies on voluntary reports to get a grip on these problems and many cases are never reported.

Continue reading "Hydroxycut Recall Lawyers: Many May Have Suffered Harmful Hydroxycut Effects" »

May 5, 2009

Hydroxycut Recall: Dietary Supplement Linked to Liver Damage

Hydroxycut recall attorneys are seeing more dietary supplement recalls.The manufacturer of the dietary supplement Hydroxycut has agreed to recall 14 of its defective products amid complaints that the widely sold supplement has caused serious liver damage, other health complications and at least one death. According to an Associated Press news report, Food and Drug Administration (FDA) officials said at least 9 million packages of this popular diet supplement were sold just in the last one year.

The FDA so far has received 23 reports of liver problems, including the death of a 19-year-old boy as a result of taking Hydroxycut. The teenager died in 2007, but the fatality wasn't reported to the FDA until March. Other patients experienced symptoms ranging from jaundice or yellowing of the skin to liver failure. One patient received a liver transplant and another awaits a liver for transplant.

Hydroxycut's U.S. distributor is Iovate Health Sciences headquartered near Buffalo, N.Y. It is manufactured by a Canadian company and is commonly available in drug stores and grocery stores nationwide in the United States. Hydroxycut is used by people who are trying to lose weight and by body builders who want to sharpen their muscles. Unfortunately, dietary supplements don't come under the same scrutiny as other prescription drugs. They are not as tightly regulated by the FDA. These dietary supplement manufacturers do not need to prove to the FDA that their products are safe and effective before selling them to consumers.

Continue reading "Hydroxycut Recall: Dietary Supplement Linked to Liver Damage" »

April 13, 2009

Defective Drug Recall: Raptiva Was Put on the Market Too Soon, Experts Say

Critics and legal experts are saying that the psoriasis Raptiva drug recall, which was recalled last week because of its link to a fatal brain infection, was put on the market too early and consumers have suffered the consequences for that act. According to an article in Lawyers and Settlements, questions are being raised about the adequacy of clinical trials. Did Genentech, manufacturer of Raptiva, study the long-term effects of their drug and conduct sufficient follow-up studies? Why did the U.S. Food and Drug Administration (FDA) drag its feet to approve a warning label for Raptiva?

Many questions remain as reports of psoriasis patients taking Raptiva getting progressive multifocal leukoencephalopathy (PML), a rare brain infection, are piling up, as are the lawsuits. FDA approved the drug in 2003. The drug accounted for $108 million in sales in 2008 for Genentech. The company is now saying that physicians should stop writing new prescriptions for the drug and that Raptiva will no longer be available after June 8. Patients are asked to consult their doctors before stopping the drug altogether because suddenly stopping it can lead to a worsening of their psoriasis.

European regulators urged the removal of Raptiva in March saying the drug's therapeutic benefits are only "modest" but its side effects are "serious." Apparently, Raptiva's side effects not only included PML, but also other serious, potentially fatal, infections such as bacterial sepsis, viral meningitis and invasive fungal disease. This was obviously a drug whose serious risks and side effects outweighed its few benefits.

Continue reading "Defective Drug Recall: Raptiva Was Put on the Market Too Soon, Experts Say" »

April 9, 2009

Raptiva Drug Recall

Defective Drug Raptiva Recalled for Links to Fatal Brain Infection

Pharmaceutical company Genentech Inc. is recalling the defective drug Raptiva, which is used to treat psoriasis because of the drug's links to a fatal brain infection, according to a news report in the San Francisco Chronicle. This voluntary drug recall from San Francisco-based Genentech comes six months after the U.S. Food and Drug Administration (FDA) approved updated labeling for the drug to warn consumers about Raptiva's links to a rare nervous system disorder called progressive multifocal leukoencephalopathy or PML. So far, there are three known confirmed fatal cases of PML in patients taking Raptiva. One other patient who was taking the drug developed similar neurological symptoms and died of an unknown cause, FDA officials said.

Genentech officials are saying that about 2,000 patients suffering from psoriasis, a skin and joint disorder, are taking the drug defective drug Raptiva here in the U.S. and about 46,000 patients worldwide have taken it since Raptiva's introduction in 2003. The drug accounted for $108 million in sales in 2008 for Genentech. The company is now saying that physicians should stop writing new prescriptions for the drug and that Raptiva will no longer be available after June 8. Patients are asked to consult their doctors before stopping the drug altogether because suddenly stopping it can lead to a worsening of their psoriasis.

Genentech first identified Raptiva's connection to the fatal brain infection in October after a 70-year-old patient died. That was when the labeling was updated to include the warning about PML. In February, the number of deaths rose to four. That has led to the company's decision to recall the drug altogether.

Continue reading "Raptiva Drug Recall" »

 
 
Web Analytics